Schwartz Jampel Syndrome Treatment Market: How Are Multidisciplinary Approaches and Emerging Genetic Therapies Addressing This Rare Chondrodystrophic Myotonia?
Schwartz-Jampel syndrome — the rare autosomal recessive disorder characterized by myotonia, skeletal dysplasia, joint contractures, and distinctive facial dysmorphism caused by hypofunctional mutations in the HSPG2 gene encoding perlecan — presents one of the most complex therapeutic challenges in pediatric neuromuscular medicine, with the Schwartz Jampel Syndrome Treatment Market...
0 Commentaires 0 Parts 525 Vue 0 Aperçu
SocioMint https://sociomint.com